CN106350485B - 一种快速高效分离单个抗原特异性b细胞的方法 - Google Patents
一种快速高效分离单个抗原特异性b细胞的方法 Download PDFInfo
- Publication number
- CN106350485B CN106350485B CN201610724209.1A CN201610724209A CN106350485B CN 106350485 B CN106350485 B CN 106350485B CN 201610724209 A CN201610724209 A CN 201610724209A CN 106350485 B CN106350485 B CN 106350485B
- Authority
- CN
- China
- Prior art keywords
- cells
- peripheral blood
- antigen
- activated
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 62
- 102000036639 antigens Human genes 0.000 title claims abstract description 62
- 108091007433 antigens Proteins 0.000 title claims abstract description 62
- 210000003719 b-lymphocyte Anatomy 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000011324 bead Substances 0.000 claims abstract description 91
- 210000004027 cell Anatomy 0.000 claims abstract description 40
- 239000003446 ligand Substances 0.000 claims abstract description 34
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims abstract description 15
- 239000006285 cell suspension Substances 0.000 claims abstract description 11
- 210000005259 peripheral blood Anatomy 0.000 claims abstract description 9
- 239000011886 peripheral blood Substances 0.000 claims abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 28
- 239000004471 Glycine Substances 0.000 claims description 14
- 238000007789 sealing Methods 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 8
- 230000000903 blocking effect Effects 0.000 claims description 8
- 229940098773 bovine serum albumin Drugs 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 210000004698 lymphocyte Anatomy 0.000 claims description 6
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 5
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 102000014914 Carrier Proteins Human genes 0.000 claims description 4
- 108010078791 Carrier Proteins Proteins 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 3
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 2
- 239000008055 phosphate buffer solution Substances 0.000 claims 6
- 239000000872 buffer Substances 0.000 claims 3
- 239000001963 growth medium Substances 0.000 claims 3
- 239000011259 mixed solution Substances 0.000 claims 3
- 239000007987 MES buffer Substances 0.000 claims 2
- -1 EDC carbodiimide Chemical class 0.000 claims 1
- YTAHJIFKAKIKAV-XNMGPUDCSA-N [(1R)-3-morpholin-4-yl-1-phenylpropyl] N-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamate Chemical compound O=C1[C@H](N=C(C2=C(N1)C=CC=C2)C1=CC=CC=C1)NC(O[C@H](CCN1CCOCC1)C1=CC=CC=C1)=O YTAHJIFKAKIKAV-XNMGPUDCSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 11
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract description 8
- 201000000050 myeloid neoplasm Diseases 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 239000006228 supernatant Substances 0.000 description 7
- 238000004132 cross linking Methods 0.000 description 6
- 210000004408 hybridoma Anatomy 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610724209.1A CN106350485B (zh) | 2016-08-24 | 2016-08-24 | 一种快速高效分离单个抗原特异性b细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610724209.1A CN106350485B (zh) | 2016-08-24 | 2016-08-24 | 一种快速高效分离单个抗原特异性b细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106350485A CN106350485A (zh) | 2017-01-25 |
CN106350485B true CN106350485B (zh) | 2020-02-21 |
Family
ID=57854183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610724209.1A Active CN106350485B (zh) | 2016-08-24 | 2016-08-24 | 一种快速高效分离单个抗原特异性b细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106350485B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108441472A (zh) * | 2018-03-16 | 2018-08-24 | 河南赛诺特生物技术有限公司 | 一种高效分离单个抗原特异性b细胞的方法 |
CN111662869A (zh) * | 2020-06-02 | 2020-09-15 | 北京康思润业生物技术有限公司 | 用于分离红细胞的免疫磁珠及其制备方法和应用 |
CN112094810B (zh) * | 2020-08-26 | 2022-07-05 | 中国农业大学 | 单b细胞筛选方法及其在小分子单克隆抗体制备中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103756967A (zh) * | 2013-12-31 | 2014-04-30 | 卢英 | 抗hla-g的单克隆抗体偶联免疫磁珠在肿瘤细胞分选中的应用 |
CN104360073A (zh) * | 2014-10-30 | 2015-02-18 | 南京爱思唯志生物科技有限公司 | 偶联免疫磁珠的肌钙蛋白诊断试纸条 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2652392C (en) * | 2006-05-19 | 2017-10-10 | Alder Biopharmaceuticals, Inc. | Culture method for obtaining a clonal population of antigen-specific b cells |
CN102719398A (zh) * | 2011-03-31 | 2012-10-10 | 赵品楠 | 一种新的高效免疫磁珠分选人t淋巴细胞的方法 |
CN102839152A (zh) * | 2011-06-20 | 2012-12-26 | 中国科学院上海生命科学研究院 | 一种快速高效获得抗原特异性b细胞的方法 |
CN104560873A (zh) * | 2014-12-04 | 2015-04-29 | 南昌大学 | 纳米磁珠法筛选呼吸道合胞病毒记忆性b细胞的方法 |
-
2016
- 2016-08-24 CN CN201610724209.1A patent/CN106350485B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103756967A (zh) * | 2013-12-31 | 2014-04-30 | 卢英 | 抗hla-g的单克隆抗体偶联免疫磁珠在肿瘤细胞分选中的应用 |
CN104360073A (zh) * | 2014-10-30 | 2015-02-18 | 南京爱思唯志生物科技有限公司 | 偶联免疫磁珠的肌钙蛋白诊断试纸条 |
Non-Patent Citations (1)
Title |
---|
EV71人源化特异性单克隆抗体分泌细胞筛选方法的建立及优化;毛怡心;《中国优秀硕士学位论文全文数据库(电子期刊)基础科学辑》;20140315;第2-3章,第32-39页,3.3.4.2 ,3.3.5.2 * |
Also Published As
Publication number | Publication date |
---|---|
CN106350485A (zh) | 2017-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6126619B2 (ja) | 細胞分離方法 | |
US5541072A (en) | Method for magnetic separation featuring magnetic particles in a multi-phase system | |
US7993864B2 (en) | Assay for identifying antibody producing cells | |
CN106350485B (zh) | 一种快速高效分离单个抗原特异性b细胞的方法 | |
CN106289927B (zh) | 一种从肿瘤细胞上清中分离微囊泡及其外泌体的方法 | |
CN105734043B (zh) | 多分选细胞分离方法 | |
US11325984B2 (en) | Method for separating cells using immunorosettes and magnetic particles | |
WO2009140876A1 (zh) | 从生物体液样本中富集与检测稀有细胞的整合方法 | |
CN105936892B (zh) | 筛选具抗原专一性融合瘤细胞的方法 | |
CN110016462A (zh) | 从脾脏细胞中高效分离单个抗原特异性b淋巴细胞的方法 | |
CA2936914C (en) | Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface | |
US20200010826A1 (en) | Simultaneous separation and activation of t cells from blood products with subsequent stimulation to expand t cells | |
US10983114B2 (en) | Method for the in situ formation of bifunctional immunological complexes | |
CN108118029A (zh) | 高抗癌活性t细胞的筛选方法和应用 | |
CN108588030B (zh) | 抗人IgM单克隆抗体、其杂交瘤细胞株及应用 | |
CN108165530B (zh) | 一种分离提纯小鼠肿瘤组织浸润cd4+cd25+调节性t细胞的方法 | |
CN115125251A (zh) | 一种高效获得特异性全人单克隆抗体基因的方法和应用 | |
CN108531460B (zh) | 抗人IgM单克隆抗体、其杂交瘤细胞株及应用 | |
US20180038863A1 (en) | Common capture cell separations done via simultaneous incubation of components | |
CN115166241B (zh) | 一种同时筛选记忆b细胞和浆细胞的高效筛选技术及应用 | |
CN110658338A (zh) | 便携式哺乳期乳腺炎致病菌mrsa检测方法 | |
CN117778309B (zh) | 动物干细胞外泌体的分离纯化方法及其应用 | |
CN117659205A (zh) | 一种分选激活磁珠的偶联方法及应用 | |
CN108531459B (zh) | 抗人IgM单克隆抗体、其杂交瘤细胞株及应用 | |
CN115161277A (zh) | 一种直接分离免疫细胞的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Fast and Efficient Method for Separating Single Antigen Specific B Cells Effective date of registration: 20230719 Granted publication date: 20200221 Pledgee: Bank of Jiangsu Limited by Share Ltd. Hangzhou branch Pledgor: HANGZHOU BAILING BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2023980049001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20200221 Pledgee: Bank of Jiangsu Limited by Share Ltd. Hangzhou branch Pledgor: HANGZHOU BAILING BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2023980049001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A rapid and efficient method for separating single antigen-specific B cells Granted publication date: 20200221 Pledgee: Bank of Jiangsu Limited by Share Ltd. Hangzhou branch Pledgor: HANGZHOU BAILING BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2024980039696 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |